STAT

J&J CEO to stay on Trump’s advisory group amid executive exodus

CEO Alex Gorsky will stay on a presidential advisory panel, declining to join an exodus of executives that began with his counterpart at Merck.
Johnson & Johnson CEO Alex Gorsky

Alex Gorsky, CEO of Johnson & Johnson, will remain on a presidential advisory panel, declining to join an exodus of executives that began with his , who stepped down in response to President Trump’s initially tepid criticism of the white nationalists at the center of the violent protests over

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Abortion Pill Arguments, A Merck Drug Approval, And More
U.S. Supreme Court justices focused on plaintiffs' right to sue the FDA to reinstate restrictions on a commonly used abortion pill, suggesting they are unlikely to restrict access.
STAT1 min read
STAT+: New Gene Therapy, To Be Priced At $4.25 Million, Has Already Transformed Children’s Lives
The world's most expensive treatment offers a near-cure for young children and redemption for its developer, but steep challenges still loom.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CAR-T Drugs For Myeloma, CVS Rebate Credits, And More
A FDA panel voted in favor of expanding use of CAR-T therapy in multiple myeloma, despite concerns about side effects.

Related